MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors

    D. Santos, T. de Deus, E. Suárez, L. Vela, M. Catalán, M. Álvarez Sauco, I. Gastón, M. Avila, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Seijo, C. Valero, J. González, S. Jesús, Ll. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, I. González Aramburu, V. Nogueira, C. Borrué, B. Solano, S. Escalante, E. Cubo, F. Carrillo, J. Kulisevsky, L. López Manzanares, M. Kurtis, M. Kurtis, P. Mir, P. Martínez Martín (A Coruña, Spain)

    Objective: To analyze quality of life (QoL) in Parkinson´s disease (PD) patients regarding to have depression, impulsive-compulsive behaviors (ICBs), or both. Background: Depression and ICBs are…
  • MDS Virtual Congress 2020

    Is Chronotype a biomarker for depression in military Veterans with Parkinson’s disease?

    A. Sarwar (Houston, TX, TX, USA)

    Objective: To determine the association of different chronotypes with depression in military Veterans with Parkinson's disease (PD). Background: Depression is a common non-motor symptom in…
  • MDS Virtual Congress 2020

    Intestinal Methanogen Overgrowth (IMO) More Prevalent than SIBO in Parkinson’s disease with Constipation: Preliminary Results

    A. Sharma, Y. Yan, T. Karunaratne, A. Eubanks, J. Kurek, J. Morgan, S. Rao (Augusta, GA, USA)

    Objective: Our aim is to quantify the prevalence of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) in PD subjects with constipation compared…
  • MDS Virtual Congress 2020

    The Presence of Efferent Brain-Gut Neuropathy Correlates with Severe Constipation in Parkinson’s disease

    A. Sharma, Y. Yan, T. Karunaratne, A. Eubanks, J. Kurek, J. Morgan, S. Rao (Augusta, GA, USA)

    Objective: We aim to correlate brain-gut neuropathy amongst cortico- and lumbosacro-anorecal efferent pathways in PD subjects with severe constipation measured by prospective stool diary. Background:…
  • MDS Virtual Congress 2020

    Intestinal transit in early-moderate Parkinson’s disease correlates with probable RBD – subclinical esophageal dysmotility does not correlate

    C. Skjærbæk, K. Knudsen, P. Borghammer (Aarhus, Denmark)

    Objective: To investigate esophageal and intestinal transit times in early-moderate Parkinson's disease (PD) and to study correlations with probable RBD and subjective symptoms. Background: Intraneuronal…
  • MDS Virtual Congress 2020

    Vitamin Deficiencies in Parkinson’s Disease: A Case for Routine Screening

    E. Smith, J. Paseka, D. Torres-Russotto, D. Bhatti, J. Bertoni (Omaha, NE, USA)

    Objective: Assess the prevalence and impact of vitamin deficiencies in Parkinson’s Disease (PD) and how nutritional intake correlates with serum levels. Background: Previous research has…
  • MDS Virtual Congress 2020

    Difference in olfactory impairment between tremor dominant and akinetic rigid dominant Parkinson’s disease patients

    P. Solla, C. Masala, P. Raffaella, S. Dagostino, T. Ercoli, G. Defazio (Monserrato, Italy)

    Objective: To investigate difference in olfactory impairment between tremor dominant (TD) and akinetic rigid dominant (ARD) Parkinson’s disease patients. Background: PD can be classified in…
  • MDS Virtual Congress 2020

    Risk of Hospital Admission in Patients with Parkinson’s disease Associated Psychosis (1991-2010)

    C. Stang, M. Hajeb, E. Camerucci, P. Turcano, A. Mullan, P. Martin, V. Abler, M. Splett, N. Rashid, J. Bower, M. Mielke, R. Savica (Rochester, MN, USA)

    Objective: To determine indicators for hospital admission in patients with Parkinson's disease (PD) and in patients with Parkinson's disease Psychosis (PDP), and to compare patients…
  • MDS Virtual Congress 2020

    Diagnostic value of olfactory dysfunction in Parkinson’s disease

    K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)

    Objective: To assess the olfactory performance in patients with PD using “Sniffin’ Sticks”. Background: Olfactory dysfunction is an important early premotor biomarker for PD, and…
  • MDS Virtual Congress 2020

    Gender-related differences in nonmotor symptoms in the context of subthalamic stimulation in Parkinson’s disease

    L. Strobel, S. Jost, A. Sauerbier, A. Rizos, K. Ashkan, M. Silverdale, J. Evans, P. Loehrer, F. Rosenkranz, M. Barbe, G. Fink, M. Samuel, K. Ray Chaudhuri, A. Antonini, P. Martinez-Martin, L. Timmermann, V. Visser-Vandewalle, H. Dafsari (Cologne, Germany)

    Objective: To investigate gender differences in quality of life, motor, and nonmotor symptoms (NMS) in patients with Parkinson’s disease (PD) undergoing subthalamic nucleus deep brain…
  • « Previous Page
  • 1
  • …
  • 1113
  • 1114
  • 1115
  • 1116
  • 1117
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley